226 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B Downtrend
Article Searches
Moving Average Crossover Alert: Jazz Pharmaceuticals (JAZZ) http://www.zacks.com/stock/news/337113/moving-average-crossover-alert-jazz-pharmaceuticals-jazz?cid=CS-ZC-FT-337113 Nov 13, 2018 - Jazz Pharmaceuticals plc (JAZZ) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
All Eyes On Walmart, Volkswagen And A Jedi Contract (Stocks To Watch Podcast) https://seekingalpha.com/article/4221002-eyes-walmart-volkswagen-jedi-contract-stocks-watch-podcast?source=feed_all_articles Nov 11, 2018 - Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks
Stocks To Watch: All Eyes On Walmart, Volkswagen And A Jedi Contract https://seekingalpha.com/article/4220754-stocks-watch-eyes-walmart-volkswagen-jedi-contract?source=feed Nov 10, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Jazz Pharma files marketing application in Europe for solriamfetol for narcolepsy/sleep apnea https://seekingalpha.com/news/3407981-jazz-pharma-files-marketing-application-europe-solriamfetol-narcolepsy-sleep-apnea?source=feed_news_all Nov 09, 2018 - Jazz Pharmaceuticals (NASDAQ:JAZZ) has filed a marketing application in Europe seeking approval for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, to improve wakefulness and
JAZZ: B. Riley FBR reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181108092433 Nov 08, 2018 - B. Riley FBR issues rating change for JAZZ
Jazz Pharma (JAZZ) Beats on Q3 Earnings, Lowers Sales View http://www.zacks.com/stock/news/336354/jazz-pharma-jazz-beats-on-q3-earnings-lowers-sales-view?cid=CS-ZC-FT-336354 Nov 08, 2018 - Jazz Pharmaceuticals (JAZZ) lowers sales guidance for 2018. Stock declines 14% following the release of third-quarter earnings.
Why Jazz Pharmaceuticals plc Stock Is Slumping Today https://www.fool.com/investing/2018/11/07/why-jazz-pharmaceuticals-plc-stock-is-slumping-tod.aspx?source=iedfolrf0000001 Nov 07, 2018 - Jazz's third-quarter earnings missed the mark, causing some investors to hit the exits today.
Jazz Pharmaceuticals Plc (JAZZ) Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4219113-jazz-pharmaceuticals-plc-jazz-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 06, 2018 - Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)Q3 2018 Earnings CallNovember 06, 2018 4:30 pm ETExecutivesKatherine A. Littrell - Jazz Pharmaceuticals PlcBruce C. Cozadd - Jazz Pharmaceuticals PlcMatthew P. Yo
Jazz Pharmaceuticals (JAZZ) Tops Q3 Earnings Estimates http://www.zacks.com/stock/news/335721/jazz-pharmaceuticals-jazz-tops-q3-earnings-estimates?cid=CS-ZC-FT-335721 Nov 06, 2018 - Jazz (JAZZ) delivered earnings and revenue surprises of 7.51% and -2.65%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals, Inc. 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4219048-jazz-pharmaceuticals-inc-2018-q3-results-earnings-call-slides?source=feed_sector_healthcare Nov 06, 2018 - The following slide deck was published by Jazz Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings call.

Pages: 123456...23

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PRGO Perrigo Company NYSE $72.57 $9.93B
BGNE BeiGene, Ltd. NASDAQ $159.91 $9.47B
ALNY Alnylam Pharmaceuticals, Inc. NASDAQ $93.43 $9.41B
NKTR Nektar Therapeutics NASDAQ $58.29 $10.05B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Jazz Pharmaceuticals plc